CCND1 and lung carcinoma: Cordycepin can bind to the AR3 to inhibit cell proliferation by inactivating glycogen synthase kinase (GSK)-3β/β-catenin signaling pathway, and subsequently suppressing cyclin D1 and c-myc expression in melanoma and lung carcinoma cells [11,67,68].